TIDMVMUK TIDM91XR
RNS Number : 2891Y
Virgin Money UK PLC
11 May 2021
Virgin Money UK PLC
(Company)
LEI: 213800ZK9VGCYYR6O495
Clydesdale Bank PLC
(Bank)
LEI: NHXOBHMY8K53VRC7MZ54
11 May 2021
Publication of Supplement to the Base Prospectus (the
"Supplement")
The following Supplement has been approved by the Financial
Conduct Authority and the International Securities Market and is
available for viewing:
First Supplement dated 11 May 2021 relating to the Base
Prospectus dated 24 March to the GBP10,000,000,000 Global Medium
Term Note Programme of the Company and the Bank
Please read the disclaimer below "Disclaimer - Intended
Addressees" before attempting to access this service, as your right
to do so is conditional upon complying with the requirements set
out below.
To view the full document, please paste the following URL into
the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/2891Y_1-2021-5-11.pdf
A copy of the above document has been submitted to the National
Storage Mechanism and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
Announcement authorised for release by Lorna McMillan, Group
Company Secretary.
Enquiries
Investors and Analysts
Richard Smith 07748 3399303
------------------------------------
Head of Investor Relations richard.smith@virginmoneyukplc.com
------------------------------------
Company Secretary
------------------------------------
Lorna McMillan 07834 585436
------------------------------------
Group Company Secretary lorna.mcmillan@virginmoneyukplc.com
------------------------------------
Media Relations
------------------------------------
Press Office 0800 066 5998
------------------------------------
press.office@virginmoneyukplc.com
------------------------------------
DISCLAIMER - INTENDED ADDRESSEES
IMPORTANT: You must read the following before continuing: The
following applies to the Supplement available by clicking on the
link above, and you are therefore advised to read this carefully
before reading, accessing or making any other use of the
Supplement. In accessing the Supplement, you agree to be bound by
the following terms and conditions, including any modifications to
them, any time you receive any information from us as a result of
such access.
THE SUPPLEMENT MAY NOT BE FORWARDED OR DISTRIBUTED OTHER THAN AS
PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER WHATSOEVER.
THE SUPPLEMENT MAY ONLY BE DISTRIBUTED OUTSIDE THE UNITED STATES TO
PERSONS THAT ARE NOT U.S. PERSONS AS DEFINED IN, AND IN RELIANCE
ON, REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED
(THE "SECURITIES ACT") OR WITHIN THE UNITED STATES TO QIBs (AS
DEFINED BELOW) IN ACCORDANCE WITH RULE 144A UNDER THE SECURITIES
ACT ("RULE 144A"). ANY FORWARDING, DISTRIBUTION OR REPRODUCTION OF
THE BASE PROSPECTUS IN WHOLE OR IN PART IS PROHIBITED. FAILURE TO
COMPLY WITH THIS NOTICE MAY RESULT IN A VIOLATION OF THE SECURITIES
ACT OR THE APPLICABLE LAWS OF OTHER JURISDICTIONS.
NOTHING IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF
SECURITIES FOR SALE IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DO
SO. ANY NOTES ISSUED OR TO BE ISSUED PURSUANT TO THE BASE
PROSPECTUS RELATING TO THE GBP10,000,000,000 GLOBAL MEDIUM TERM
NOTE PROGRAMME OF THE COMPANY AND THE BANK DATED 24 MARCH 2021 (AS
SUPPLEMENTED ON BY THIS SUPPLEMENT, THE "BASE PROSPECTUS") HAVE NOT
BEEN, AND WILL NOT BE, REGISTERED UNDER THE SECURITIES ACT OR THE
SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION OF THE UNITED
STATES. ANY NOTES ISSUED OR TO BE ISSUED PURSUANT TO THE BASE
PROSPECTUS MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE
TRANSFERRED EXCEPT (1) IN ACCORDANCE WITH RULE 144A UNDER THE
SECURITIES ACT TO PERSONS REASONABLY BELIEVED TO BE QUALIFIED
INSTITUTIONAL BUYERS (EACH A "QIB") WITHIN THE MEANING OF RULE 144A
OR (2) IN AN OFFSHORE TRANSACTION TO A PERSON THAT IS NOT A U.S.
PERSON IN RELIANCE ON REGULATION S UNDER THE SECURITIES ACT.
The Supplement must be read in conjunction with the Base
Prospectus which comprises a prospectus for the purposes of the
Regulation (EU) 2017/119 as it forms part of domestic law of the
United Kingdom by virtue of the European Union (Withdrawal) Act
2018, as amended (the "UK Prospectus Regulation").
Please note that the information contained in the Base
Prospectus may be addressed to and/or targeted at persons who are
residents of particular countries (specified in the Base
Prospectus) only and is not intended for use and should not be
relied upon by any person outside these countries and/or to whom
the offer contained in the Base Prospectus is not addressed. Prior
to relying on the information contained in the Base Prospectus you
must ascertain from the Base Prospectus (as applicable) whether or
not you are part of the intended addressees of the information
contained therein.
Confirmation of your Representation: In order to be eligible to
view the Base Prospectus or make an investment decision with
respect to any Notes issued or to be issued pursuant to the Base
Prospectus, you must be (A) a person other than a U.S. person
(within the meaning of Regulation S under the Securities Act); or
(B) a QIB that is acquiring the securities for its own account or
for the account of another QIB. By accessing the Base Prospectus,
you shall be deemed to have represented that you and any customers
you represent are not a U.S. person (as defined in Regulation S to
the Securities Act) or that you are a QIB, and that you consent to
delivery of the Base Prospectus thereto via electronic
publication.
You are reminded that the Supplement has been made available to
you on the basis that you are a person into whose possession the
Supplement may be lawfully delivered in accordance with the laws of
the jurisdiction in which you are located and you may not, nor are
you authorised to, deliver the Supplement to any other person.
The Supplement and the Base Prospectus do not constitute, and
may not be used in connection with, an offer or solicitation in any
place where offers or solicitations are not permitted by law. If a
jurisdiction requires that the offering be made by a licensed
broker or dealer and the underwriters or any affiliate of the
underwriters is a licensed broker or dealer in that jurisdiction,
the offering shall be deemed to be made by the underwriters or such
affiliate on behalf of the Company or the Bank in such
jurisdiction. Under no circumstances shall the Supplement and the
Base Prospectus constitute an offer to sell, or the solicitation of
an offer to buy, nor shall there be any sale of any Notes issued or
to be issued pursuant to the Supplement or the Base Prospectus, in
any jurisdiction in which such offer, solicitation or sale would be
unlawful.
The Supplement has been made available to you in an electronic
form. You are reminded that documents transmitted via this medium
may be altered or changed during the process of electronic
transmission and consequently none of the Company, the Bank, its
advisers or any person who controls the Company, the Bank, or any
director, officer, employee or agent of the Company, the Bank or
affiliate of any such person accepts any liability or
responsibility whatsoever in respect of any difference between the
Supplement made available to you in electronic format and the hard
copy version available to you on request from the Company or the
Bank.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PSPGPUCCAUPGGQG
(END) Dow Jones Newswires
May 11, 2021 12:55 ET (16:55 GMT)
Ve Bionic Etf (LSE:CYBG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ve Bionic Etf (LSE:CYBG)
Historical Stock Chart
From Apr 2023 to Apr 2024
